USPO Grants Patent to Zecotek for Switchable 3D/2D Optical Imaging System

Zecotek Photonics Inc., a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that the U.S. Patent office has granted U.S. Patent No. 9,055,288 to Zecotek for technology related to the Company's switchable 3D/2D optical imaging system. This patent adds to the global portfolio of patents, including U.S. patent number 7,944,465 covering Zecotek's glasses-free 3D auto-stereoscopic display system.

"This U.S. patent marks another important step in our continued efforts to provide the best-in-class glasses-free 3D displays and monitors," said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. "The patent covers the significant improvements to our switchable 3D/2D display technology which meet the practical needs of OEM's and end users. Our 3D display technology allows for switching between 3D and 2D modes without loss of resolution, and displaying 3D and 2D content simultaneously. The patent also covers technology which significantly broadens the capabilities of specialized 3D display applications such as fundamental research and medical imaging. We are working closely with OEM's within well-defined markets and will continue to maintain an aggressive IP development program in parallel with our efforts to meet market requirements."

The 3D/2D switchable optical imaging system further improves the core capabilities of the 3D display technology by introducing a software-selectable full-resolution 2D mode with viewing angles and dynamic range/colour depth on par with conventional 2D displays. The patent also covers technology for both 3D and 2D modes, dynamic adjustment of viewing angle, number and width of viewing zones as well as the functionality to dynamically control the positioning of different viewing zones.

Patents have been granted to Zecotek for its 3D display system in the United States, China, Europe, Eurasia, Russia and Australia. Other patents have been filed and are pending in Japan, Korea and India.

Source: http://www.zecotek.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Zecotek Photonics. (2019, February 25). USPO Grants Patent to Zecotek for Switchable 3D/2D Optical Imaging System. AZoOptics. Retrieved on February 27, 2024 from https://www.azooptics.com/News.aspx?newsID=20975.

  • MLA

    Zecotek Photonics. "USPO Grants Patent to Zecotek for Switchable 3D/2D Optical Imaging System". AZoOptics. 27 February 2024. <https://www.azooptics.com/News.aspx?newsID=20975>.

  • Chicago

    Zecotek Photonics. "USPO Grants Patent to Zecotek for Switchable 3D/2D Optical Imaging System". AZoOptics. https://www.azooptics.com/News.aspx?newsID=20975. (accessed February 27, 2024).

  • Harvard

    Zecotek Photonics. 2019. USPO Grants Patent to Zecotek for Switchable 3D/2D Optical Imaging System. AZoOptics, viewed 27 February 2024, https://www.azooptics.com/News.aspx?newsID=20975.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Azthena logo with the word Azthena

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.